Protective effects of the melanocortin analog NDP-α-MSH in rats undergoing cardiac arrest

Eur J Pharmacol. 2014 Dec 15:745:108-16. doi: 10.1016/j.ejphar.2014.10.022. Epub 2014 Oct 22.

Abstract

We previously reported that melanocortins afford cardioprotection in conditions of experimental myocardial ischemia/reperfusion, with involvement of the janus kinases (JAK), extracellular signal-regulated kinases (ERK) and signal transducers and activators of transcription (STAT) signalings. We investigated the influence of the melanocortin analog [Nle(4), D-Phe(7)]α-melanocyte-stimulating hormone (NDP-α-MSH) on short-term detrimental responses to cardiac arrest (CA) induced in rats by intravenous (i.v.) administration of potassium chloride, followed by cardiopulmonary resuscitation (CPR) plus epinephrine treatment. In CA/CPR rats i.v. treated with epinephrine (0.1 mg/kg) and returned to spontaneous circulation (48%) we recorded low values of mean arterial pressure (MAP) and heart rate (HR), alteration of hemogasanalysis parameters, left ventricle low expression of the cardioprotective transcription factors pJAK2 and pTyr-STAT3 (JAK-dependent), increased oxidative stress, up-regulation of the inflammatory mediators tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), and down-regulation of the anti-inflammatory cytokine IL-10, as assessed at 1h and 3h after CPR. On the other hand, i.v. treatment during CPR with epinephrine plus NDP-α-MSH (340 μg/kg) almost completely restored the basal conditions of MAP and HR, reversed metabolic acidosis, induced left ventricle up-regulation of pJAK2, pTyr-STAT3 and IL-10, attenuated oxidative stress, down-regulated TNF-α and IL-6 levels, and improved survival rate by 81%. CA/CPR plus epinephrine alone or in combination with NDP-α-MSH did not affect left ventricle pSer-STAT3 (ERK1/2-dependent) and pERK1/2 levels. These results indicate that melanocortins improve return to spontaneous circulation, reverse metabolic acidosis, and inhibit heart oxidative stress and inflammatory cascade triggered by CA/CPR, likely via activation of the JAK/STAT signaling pathway.

Keywords: Cardiac arrest; Epinephrine; JAK/ERK/STAT signaling; Melanocortins; Metabolic acidosis; Resuscitation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Carbon Dioxide / blood
  • Cardiopulmonary Resuscitation
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / pharmacology*
  • Cytokines / metabolism
  • Epinephrine / administration & dosage
  • Epinephrine / pharmacology
  • Heart Arrest / drug therapy*
  • Heart Arrest / pathology
  • Heart Arrest / physiopathology
  • Hemodynamics / drug effects
  • Inflammation Mediators / metabolism
  • Janus Kinase 2 / metabolism
  • MAP Kinase Signaling System / drug effects
  • Male
  • Melanocortins / administration & dosage
  • Melanocortins / pharmacology
  • Melanocortins / physiology
  • Oxidative Stress / drug effects
  • Oxygen / blood
  • Rats
  • Rats, Sprague-Dawley
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • alpha-MSH / administration & dosage
  • alpha-MSH / analogs & derivatives*
  • alpha-MSH / pharmacology

Substances

  • Cardiotonic Agents
  • Cytokines
  • Inflammation Mediators
  • Melanocortins
  • STAT3 Transcription Factor
  • Stat3 protein, rat
  • Carbon Dioxide
  • alpha-MSH
  • MSH, 4-Nle-7-Phe-alpha-
  • Jak2 protein, rat
  • Janus Kinase 2
  • Oxygen
  • Epinephrine